Dingdang Health Technology Group Future Growth
Future criteria checks 1/6
Dingdang Health Technology Group is forecast to grow earnings and revenue by 98.7% and 10.7% per annum respectively. EPS is expected to grow by 95.7% per annum. Return on equity is forecast to be -0.5% in 3 years.
Key information
98.7%
Earnings growth rate
95.7%
EPS growth rate
| Consumer Retailing earnings growth | 25.5% |
| Revenue growth rate | 10.7% |
| Future return on equity | -0.5% |
| Analyst coverage | Low |
| Last updated | 01 Apr 2024 |
Recent future growth updates
No updates
Recent updates
We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth
Apr 16
We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth
Dec 12We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth
Jul 26Estimating The Intrinsic Value Of Dingdang Health Technology Group Ltd. (HKG:9886)
Dec 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 6,026 | -10 | N/A | 102 | 1 |
| 12/31/2024 | 5,429 | -92 | N/A | 17 | 1 |
| 12/31/2023 | 4,857 | -226 | -26 | -5 | N/A |
| 9/30/2023 | 4,722 | -1,297 | -46 | -28 | N/A |
| 6/30/2023 | 4,587 | -2,368 | -67 | -50 | N/A |
| 3/31/2023 | 4,465 | -2,491 | -169 | -146 | N/A |
| 12/31/2022 | 4,329 | -2,833 | -264 | -238 | N/A |
| 9/30/2022 | 4,177 | -1,951 | -259 | -233 | N/A |
| 6/30/2022 | 4,025 | -1,069 | -255 | -228 | N/A |
| 3/31/2022 | 3,886 | -1,232 | -290 | -266 | N/A |
| 12/31/2021 | 3,679 | -1,578 | -320 | -295 | N/A |
| 12/31/2020 | 2,229 | -924 | -215 | -193 | N/A |
| 12/31/2019 | 1,276 | -277 | -292 | -266 | N/A |
| 12/31/2018 | 585 | -108 | -1 | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9886 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 9886 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 9886 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 9886's revenue (10.7% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 9886's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9886 is forecast to be unprofitable in 3 years.